Table 3.
Differences of outcome surrogates depending on fasting low-density lipoprotein levels and hyperlipidemia (defined as LDL ≥ 100 mg/dl)
| Fasting LDL (mg/dl, median[IQR]) | |||
| mRS at 3 months | 0–2 (n = 83) | 3–6 (n = 83) | p value |
| 105 (85–124) | 78 (62–102) | < 0.001 | |
| Hospital death | No (n = 152) | Yes (n = 22) | |
| 93 (74–119) | 69 (45–93) | 0.002 | |
| Presence of hyperlipidemia | |||
| Outcome | Present (%) | Absent (%) | p value |
| mRS 0–2 at 3 months (n = 83) | 45 (54.2) | 23 (27.7) | 0.001 |
| Hospital death (n = 22) | 5 (22.7) | 17 (77.3) | 0.066 |
| Final infarct volume (cm3) | 25.8 (4.2–102.6) | 32.6 (4.4–154.1) | 0.702 |
Interval variables between groups were compared using the non-parametric Kruskal-Wallis test and comparisons between proportions using Fisher’s exact test